1614P PSA responses and PSMA scan changes after immunotherapy for biochemically recurrent prostate cancer (BCR) without androgen deprivation therapy (ADT)

• DOI: 10.1016/j.annonc.2024.08.1695
• Publication Date: 2024-09-17T20:46:08Z
• Authors: R.A. Madan; E. Mena Gonzalez; E.B.A. Chandran; J.B. Aragon-Ching; P.M. Arlen; L. Lindenberg; C. Chen; L. Cordes; S. McMahon; E. Lamping; A. Hankin; N. Williams; Y. McKinney; W. Figg; J.L. Gulley; P.L. Choyke; F. Karzai
• Keywords: Recurrent prostate cancer; breakpoint cluster region